SCHEMBL19722084

SCHEMBL19722084

C=C(CN(CC)CC)C(=O)OC1CCC(CCCCC)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 3/20 0.39
▸ TP53 P04637 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ CYP1A2 P05177 3/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ POLB P06746 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CCR2 P41597 1/20 0.31
▸ LSS P48449 2/20 0.31
▸ KDM5A P29375 1/20 0.31
▸ KDM7A Q6ZMT4 1/20 0.31
▸ KDM4C Q9H3R0 1/20 0.31
▸ PHF8 Q9UPP1 1/20 0.31
▸ KDM2A Q9Y2K7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19721914 0.96 NAAA (0.37) NAAATP53PKMMEN1KMT2A
SCHEMBL19722453 0.90 NAAA (0.40) NAAATP53PKMMEN1KMT2A
SCHEMBL19722472 0.88 TLR4 (0.34) NAAACYP2C9
SCHEMBL19722318 0.88 NAAA (0.39) NAAATP53PKMMEN1KMT2A
SCHEMBL19722120 0.85 NAAA (0.38) NAAATP53PKMMEN1KMT2A
SCHEMBL19722300 0.84 NAAA (0.37) NAAATP53PKMMEN1KMT2A
SCHEMBL19721998 0.83 NAAA (0.42) NAAATP53PKMMEN1KMT2A
SCHEMBL19722515 0.82 NAAA (0.41) NAAATP53PKMMEN1KMT2A
SCHEMBL19722111 0.82 NAAA (0.41) NAAATP53PKMMEN1KMT2A
SCHEMBL19722087 0.82 NAAA (0.41) NAAATP53PKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3257839-B1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2019-09-04 — — EP disclosed
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2019-08-27 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORPORATION (JP) 2017-12-28 — — US disclosed
EP-3257839-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2017-12-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element SP1, HVCN1, CXCR1 NAAA 4846/4885TP53 1932/4885PKM 2458/4885
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT SP1, SPIN1, SAV1 NAAA 4714/4885TP53 1968/4885PKM 2948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback